and the thyroid hormone receptor β (TRβ) (Wagner et al., 1995) , that ligand binding results in an alteration in The oestrogen receptor is a member of the nuclear conformation of the ligand-binding domain to generate a receptor family of transcription factors which, on novel surface required for the formation of AF2. This binding the steroid hormone 17β-oestradiol, interacts results in part from the reorientation of an α-helix, helix with co-activator proteins and stimulates gene expres-12 (H12), across the ligand-binding pocket which is sion. Replacement of a single tyrosine in the hormonestabilized both by the ligand itself and by interactions binding domain generated activated forms of the between H12 and helices 3 and/or 4. The amphipathic receptor which stimulated transcription in the absence character of the amino acids which form H12 is conserved of hormone. This increased activation is related to a in the majority of members of the nuclear hormone decrease in hydrophobicity and a reduction in size of receptor superfamily (Danielian et al., 1992 ; Saatcioglu the side chain of the amino acid with which the tyrosine et al., 1993; Barettino et al., 1994; Durand et al., 1994 ) is replaced. Ligand-independent, in common with and this helix forms the AF2 activation helix, AF2 AH.
ligand-dependent transcriptional activation, requires
The amino acids predicted to form H12 in the ER (Wurtz an amphipathic α-helix at the C-terminus of the et al., 1996) are completely conserved in primary sequence ligand-binding domain which is essential for the interbetween different species, and mutations in either the action of the receptor with a number of potential cocharged or hydrophobic amino acids result in receptor activator proteins. In contrast to the wild-type protein, proteins which bind oestradiol but are impaired in ligandconstitutively active receptors were able to bind both dependent transcriptional activation (Danielian et al. , the receptor-interacting protein RIP-140 and the 1992). steroid receptor co-activator SRC-1 in a ligandIn addition to ligand binding, a number of the nuclear independent manner, although in the case of SRC-1 receptors may also be activated by different signalling this was only evident when the receptors were prepathways, including those stimulated by the neurobound to DNA. We propose, therefore, that this tyrosine transmitter dopamine (Power et al., 1991; , is required to maintain the receptor in a transcrip -1993) , growth factors such as epidermal growth factor tionally inactive state in the absence of hormone.
(EGF), transforming growth factor-α (TGF-α) and insulinModification of this residue may generate a conformalike growth factor I (IGF-I) (Ignar-Trowbridge et al., tional change in the ligand-binding domain of Aronica and Katzenellenbogen, 1993 ; Bunone receptor to form an interacting surface which allows the et al., 1996) , and by activators of protein kinase AIntroduction receptor (Rao and Fox, 1987) and the orphan receptor HNF-4 (Ktistaki et al., 1995) are also targets for tyrosine The oestrogen receptor α (ER) is a member of a large phosphorylation. A specific tyrosine phosphorylation site family of nuclear hormone receptors which are charachas been identified within the AF2 domain of the human terized by a highly conserved DNA-binding domain and ER (hER) at amino acid 537 (Y537) (Castoria et al., 1993 ; function as transcription factors in target cells (Parker, Arnold et al., 1995a) . This tyrosine is located immediately 1993; Beato et al., 1995; Mangelsdorf et al., 1995) . The N-terminal of the AF2 AH sequence and is conserved in N-terminal region of the ER contains a transcriptional all known ER sequences from diverse species including activation function termed AF1 while the C-terminal the novel receptor ERβ (Kuiper et al., 1996 ; Mosselman region is required for high affinity ligand binding and contains a ligand-inducible transactivation function termed et al., 1996) .
A number of proteins have been identified which interact with the ligand-binding domains of nuclear hormone receptors in the presence of ligand and have been proposed or demonstrated to act as co-activators in hormoneregulated gene transcription. These include RIP-140 and RIP-160 (Cavaillès et al., , 1995 , ERAP-140 and ERAP-160 (Halachmi et al., 1994) , TIF1 (Le Douarin et al., 1995) , TRIP1/SUG-1 (Lee et al., 1995; vom Baur et al., 1996) TIF2 (Voegel et al., 1996) and a series of SRC-1 isoforms (Onate et al., 1995; Kamei et al., 1996) . In addition, interactions have been demonstrated between SRC-1, nuclear hormone receptors and the co-activator CBP/p300 (Chakravarti et al., 1996; Kamei et al., 1996; Yao et al., 1996) , and overexpression of CBP/p300 has been shown to potentiate ligand-dependent transcription (Chakravarti et al., 1996; Smith et al., 1996) . The results of mutagenesis studies and structural predictions suggest that the interaction of these proteins with receptors may depend on the integrity of the AF2 AH (Danielian et al., 1992; Bourguet et al., 1995) and its realignment following ligand binding (Renaud et al., 1995; Wagner et al., 1995) . In view of the close proximity of the conserved tyrosine in the ERs relative to AF2 AH and its identification as a site of phosphorylation, we have investigated whether it may be required or involved in the modulation of AF2 activity in the ER. Point mutations have, therefore, been introduced at tyrosine 541 (Y541) in the mouse ER, and the resulting proteins have been analysed for their ability to interact with potential co-activator proteins in vitro in the presence and absence of DNA, and to transactivate in transient transfection studies when expressed in mamma- amino acid with a hydrophobic side chain similar in size and structure to tyrosine but which lacks a hydroxyl group and cannot be modified by phosphorylation. Mutants were ( Figure 1C ). The transcriptional activity of the mutant receptor Y541-F was similar to that of the wild-type also generated in which Y541 was altered to either the negatively charged amino acids aspartic acid (Y541-D) receptor in the presence of oestradiol, although the activation observed in the absence of added hormone was found and glutamic acid (Y541-E) or to alanine (Y541-A). In transient transfection studies in HeLa cells, the wild-type consistently to be slightly reduced. The receptors Y541-D, Y541-E and Y541-A were also able to activate tranreceptor (MOR 1-599) stimulated transcription from an ERE-TK-luciferase reporter gene 3-to 4-fold and this was scription to levels similar to the wild-type in the presence of oestradiol, demonstrating that the tyrosine residue increased~3-fold further in the presence of oestradiol 4-hydroxytamoxifen, demonstrating that ligand-dependent and ligand-independent activation of transcription may occur, in part, by a common mechanism.
To determine if the increase in transactivation by the mutant receptors was derived from activation of AF2 or required the presence of AF1, the point mutations described above were introduced into a chimeric receptor consisting of the ligand-binding domain fused to the DNA-binding domain of GAL4 and expressed together with a GAL4 reporter gene in HeLa cells ( Figure 2A ). The wild-type GAL4-AF2 receptor stimulated transcription from the reporter up to 100-fold in the presence of oestradiol. GAL4-AF2 Y541-F stimulated transcription in the presence of oestradiol, but was slightly reduced in activity compared with the wild-type AF2 in the absence of hormone. Chimeric proteins containing the point mutations Y541-D, Y541-E and Y541-A all showed enhanced levels of transcription in the absence of oestradiol compared partial activation of AF2 in the absence of hormone. The constitutive activity observed when Y541 mutations are introduced into the full-length protein may result from coadjacent to AF2 AH is not required for oestrogendependent transcriptional activation. However, in contrast operation between AF1 and AF2 or the partial activation of AF2 combined with activation of AF1 by other signalling to the wild-type receptor and the mutant Y541-F, replacement of the tyrosine with a charged amino acid or alanine pathways. generated receptors with enhanced basal activity similar to that observed in the presence of added hormone. This Mutation of tyrosine 541 does not affect ligand binding or DNA binding suggests that this tyrosine residue may be involved in maintaining AF2 in an inactive state. Equivalent results Expression of the wild-type and mutant receptors was verified by Western blotting and immunofluorescence (our were obtained over a range of receptor expression vector concentrations and also in other cell lines of mammary unpublished data). All receptor proteins bound ligand with similar affinities (Table I ) and bound to DNA as dimers epithelial origin including MTSV1-7 cells and CE1 cells (D'Souza et al., 1993) (our unpublished data). The in a gel retardation assay (Figure 3) . In all cases, the mobility of the receptor-DNA complexes was slightly hormone-dependent and the hormone-independent activity of both the wild-type and mutant receptors was inhibited increased by the addition of oestradiol and retarded by the ER-specific antibody MP16. Therefore, mutant recepby treatment with the anti-oestrogens ICI 182,780 or for each panel represents 10% of the total volume of the lysate used in retardation assay using a 32 P-labelled oligonucleotide containing a each reaction. single oestrogen response element (ERE) corresponding to the sequence from the vitellogenin A2 gene. Prior to electrophoresis, the samples were treated with either ethanol vehicle alone, oestradiol (E2) at 1ϫ10 -7 M or the ER-specific antiserum MP16. Protein-DNA complexes were resolved on 6% polyacrylamide gels in 1ϫ Tris/ glycine buffer and detected by autoradiography.
tors with enhanced ligand-independent transcriptional activity were unaffected in the properties of ligand binding and DNA binding.
Differential interaction of RIP-140 and SRC-1 with activated receptors in vitro
A number of proteins have been identified which interact the wild-type mER and the Y541-F mutant interact with both RIP-140 and SRC-1 in an oestrogen-dependent man-AF2) in an oestrogen-dependent manner. Similarly, the interaction of GST-AF2 Y541-F with SRC-1 and RIPner whereas the constitutive mutants Y541-D, Y541-E and Y541-A interact with both proteins in the absence of 140 was also oestrogen dependent; however, GST fusion proteins of the AF2 mutants Y541-D, Y541-E and Y541-hormone. Thus, the recruitment of SRC-1 to the activated mutant receptors may depend on the presence of additional A interact with RIP-140 in both the absence and the presence of ligand. In contrast, the ability of these mutant factors in the cell lysates or a further conformational change in the ligand-binding domain which appears to receptors to bind SRC-1 was still oestrogen dependent, with no interaction observed in solution in the absence of occur upon DNA binding. oestradiol. The difference in the binding affinities of RIP-140 and SRC-1 in the absence of ligand may reflect Co-activator proteins enhance ligand-independent transactivation their interaction with distinct surfaces on the ligandbinding domain.
The effect of the overexpression of RIP-140 and SRC-1 on the AF2 activity was analysed using co-transfection We next examined the ability of RIP-140 and SRC-1 to interact with the wild-type and mutant receptors preexperiments in HeLa cells. Overexpression of RIP-140 ( Figure 6A ) resulted in a reduction in ligand-dependent bound to DNA. The receptors were overexpressed in transactivation by GAL4-AF2, as previously described (Cavaillès et al., 1995) , and also reduced transactivation by GAL4-AF2 Y541-A in both the absence and presence of oestradiol. Expression of SRC-1 ( Figure 6B ) enhanced the ligand-dependent activity of GAL4-AF2 and GAL4-AF2 Y541-A by~2-to 3-fold and stimulated the ligandindependent activity by~4-fold. Although expression of SRC-1 stimulated the ligand-independent activity of the wild-type receptor, its overall activity, in contrast to that of the Y541-A mutant, was almost entirely dependent on the addition of ligand.
Ligand-independent activity requires AF2 AH
Mutations of the hydrophobic amino acids in AF2 AH have been demonstrated to inhibit the ligand-dependent activity of the mER in transfection studies (Danielian et al., 1992) and also to prevent the binding of receptorinteracting proteins such as RIP-140 in vitro (Cavaillès et al., 1995) . The role of AF2 AH in ligand-independent activation was therefore examined, in the context of the full-length receptor MOR 1-599, by combining the mutations at Y541 with the mutations in H12. The effect of the combined mutations was analysed in transient transfection studies in HeLa cells (Figure 7) . Mutations in hydrophobic residues in AF2 AH inhibited ligand- RIP-140 or SRC-1 has no effect on either a hydrophobic and assayed for luciferase and β-galactosidase activities. Normalized mutant alone or the combined mutant receptor. Therefore, values were determined from a minimum of three independent experiments with all samples assayed in duplicate.
the ability of the ER to activate transcription in the absence of ligand may be modulated by co-activator proteins and Le Goff et al., 1994; Arnold et al., 1995b) and on tyrosine residues (Auricchio et al., 1987; Arnold et al., 1995a,d ; requires the formation of an interacting surface similar to that which is generated as a result of ligand binding. Pietras et al., 1995) , suggesting that it may be a target for different signalling pathways (Kato et al., 1995; Bunone et al., 1996) . In addition, although it has been reported Discussion that dimerization and DNA binding of the hER are regulated by phosphorylation at Y537 (Arnold et al., The main conclusion from this study is that a tyrosine at the N-terminus of a conserved helix, which forms a major 1995d), we find that these properties are unaffected in any of the mutants tested here. Furthermore, it has been part of the ligand-dependent activation function in the ER, is required to maintain the receptor in a transcriptionally
shown that the C-terminal region of the ER, including the tyrosine residue at position 541, can be deleted without inactive state in the absence of hormone. The conserved helix corresponds to helix 12 (H12) of the ligand-binding disrupting either ligand-binding, dimerization or DNAbinding properties of the receptor (Fawell et al., 1990a) . domain of nuclear receptors (Wurtz et al., 1996) . In the absence of ligand, amino acids at the N-terminus of H12
In particular, the lack of an absolute requirement for phosphorylation at this site is demonstrated by the ability appear to interact with residues in the loop between helices 2 and 3 (Bourguet et al., 1995) . It is proposed that of all the mutant receptors to transactivate to a similar level to the wild-type protein in the presence of oestradiol. following ligand binding this interaction may be disrupted, allowing helices 10 and 11 to rearrange to form one Phosphorylation at this site, however, would decrease the potential for hydrophobic interactions between the tyrosine continuous helix while a shortened H12 realigns over the ligand-binding pocket (Renaud et al., 1995; Wagner et al., and other parts of the ligand-binding domain and therefore may be an alternative means of receptor activation. 1995). This alteration of the position of H12 involves the introduction of a kink or break in the helical structure at
The mechanism of ligand-independent activation may depend on a combination of two processes. Firstly, modiproline residue(s) which are highly conserved at this position in the nuclear hormone receptors. The realignment fication of the receptor by the action of a tyrosine kinase might facilitate the disassembly of aporeceptor complexes. of H12 against the core of the ligand-binding domain in combination with helices 3 and/or 4 may result in the This could result from a reduced association with DnaJ/ Hsp70 family members and the loss of interaction with formation of a novel interacting surface to which coactivators bind (Parker and White, 1996; Henttu, et al., Hsp90, generating a pool of unliganded active receptor similar to that proposed from studies of steroid receptor 1997).
It has been proposed based on sequence homology that function in ydj1 mutant strains of yeast (Bohen et al., 1995; Caplan et al., 1995; Kimura et al., 1995) . Preliminary the helical structure of the ligand-binding domain may be conserved as a common fold for all nuclear hormone studies, however, indicate that the activated mutant receptors used in this study retain the ability to interact with receptors, including the ER (Wurtz et al., 1996) . It is conceivable, therefore, that Y541 in the mER, which is at Hsp90 in vitro (our unpublished data). Secondly, it is possible that ligand-independent activation may result the N-terminus of the realigned H12, is involved in hydrophobic interactions with the loop between helices 2 from a conformational change which generates an interacting surface that is capable either of recruiting different and 3 in the ligand-binding domain in the absence of oestradiol and that these are maintained or strengthened co-activators required for receptor-mediated transcription, or altering the binding affinity of potential co-activator when this residue is replaced by phenylalanine, an amino acid with a planar structure similar to tyrosine. Reducproteins for the ligand-binding domain. The demonstration that anti-oestrogens inhibit both ligand-dependent and tion in either the hydrophobicity or the size of the side chain of the amino acid at this position with charged ligand-independent transcriptional activity probably reflects their ability to interfere with the correct reamino acids or a neutral amino acid such as alanine, would reduce the stability of the interactions, resulting alignment of H12 with helices 3/4 and thereby prevent the recruitment of co-activators. These results, together in the release of H12 from its inactive conformation. Interestingly, it is the introduction of alanine, an amino with the analysis of receptors in which mutations at Y541 have been combined with mutations in the hydrophobic acid with a small alkyl group side chain, which results in the greatest hormone-independent activation of AF2 when amino acids of AF2 AH, demonstrate that both the liganddependent and the ligand-independent activity of the ER it is fused to a heterologous DNA-binding domain. Comparison of the primary sequence of the ER with other result from a common mechanism. Since mutations in AF2 AH prevent interaction between nuclear hormone receptors reveals that although a tyrosine is conserved in the ERα from diverse species and in the the ligand-binding domain of the receptor and potential co-activator proteins , the activated related isoform ERβ, a number of other receptors contain a hydrophobic residue in a similar position immediately receptors were analysed for their interaction with two different types of co-activator in vitro. The ability of the N-terminal to either the charged amino acid or the proline at the predicted start of H12. It is conceivable, therefore, Y541 mutants to interact with RIP-140 but not SRC-1 in a hormone-independent manner in the GST pull-down that the ligand-binding domains of a number of receptor proteins may be maintained in an inactive conformation assay, in contrast to both co-activators being able to interact when receptors are bound to DNA, implies that by similar hydrophobic interactions. The lack of conservation of this tyrosine may reflect a mechanism of differential different surfaces of the AF2 domain may be involved in the interaction with these proteins and that a conformasignalling specific for the ER.
The ER has been demonstrated to be phosphorylated tional change is induced in the receptor on DNA binding. It is conceivable, therefore, that RIP-140 may associate on serine residues (Ali et al., 1993; Lahooti et al., 1994 ; (Chen and Okayama, 1987) with 1 μg of reporter plasmid, 300 ng of with the receptor prior to the binding of more potent copCMV-βGal plasmid as an internal control, pMT2 expression plasmids activators such as SRC-1 as a result of a difference in the at 30 ng/well, pGAL4 expression plasmids at 200 ng/well or, as detailed relative affinities of these proteins for the receptor in in the figure legends, together with the expression vectors pMT2 or the presence and absence of DNA. Alternatively, pSG424 to a total of 1.8 μg of DNA per well. The reporters were either pERE-TK-LUC or p(GAL) 5 CAT. In some experiments, pEFRIP (0.5-additional factors, or modification of the receptors in the 50 ng) (Cavaillès et al., 1995) or pSG5-SRC-1 (300 ng) was added cell lysate in which they are expressed, may facilitate together with the appropriate expression vector to maintain a constant the binding of SRC-1 in the presence of DNA. amount of DNA. After 24 h, the cells were washed and then maintained It has been proposed from studies using either in vitro in medium containing 10% DCFBS and phenol red-free DMEM in the presence or absence of ligand(s) as described in the figure legends. The translated proteins (Castoria et al., 1993) , or from breast cells were then washed with phosphate-buffered saline and harvested in tumour samples reported to be devoid of ligand-binding lysis buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 150 mM NaCl, activity (Castoria et al., 1996) , that phosphorylation of and 0.65% NP-40). Extracts were assayed for luciferase (Danielian et al., the conserved tyrosine results in the conversion of a non-1992), CAT (Sleigh, 1986) or β-galactosidase activity, as control, using hormone-binding form of the ER to a hormone-binding a Galacto-Light chemiluminescent assay (Tropix). For gel retardation, ligand-binding and protein-protein interaction assays, the wild-type and form. Since receptors in which this tyrosine has been mutant receptors were overexpressed in COS-1 cells by electroporation phosphorylated (Castoria et al., 1993) , or modified by at 450 V and 250 μF in the presence of 20 μg of plasmid DNA. Cells mutagenesis as described in this study, bind ligand with were then plated out in DMEM containing 10% DCFBS and grown for an affinity similar to the wild-type receptor, it is conceiv-48 h. Whole cell extracts were prepared in buffer containing 0.4 M KCl, 20 mM HEPES (pH 7.4), 1 mM dithiothreitol and 20% glycerol. The able that phosphorylation at this site may alter the ligandprotein content of cell extracts was determined using a colorimetric binding domain to a more active conformation which has method (Bio-Rad).
an enhanced ability to stimulate transcription or promote cell growth in an ER-dependent but ligand-independent Gel retardation and ligand-binding assays manner. The demonstration that the hER may be phos-
The DNA-binding activity of the mutant receptors was determined essentially as described in Danielian et al. (1992) . Cell extracts from phorylated in vitro on Y537 by src-family tyrosine kinases transfected COS-1 cells were incubated with 32 P-labelled annealed (Arnold et al., 1995a) , combined with the mutagenesis oligonucleotides consisting of a 32 bp fragment of the vitellogenin A2 studies described here, suggests that tyrosine phosphorylagene promoter containing a consensus oestrogen response element. tion may result in the recruitment of co-activators to the Binding reactions were performed in the presence of ethanol, or 10 -7 M 17β-oestradiol, and the antibody MP16 specific to ERs (Fawell et al., ligand-binding domain of the receptor. The observation 1990b) was added as indicated. Receptor-DNA complexes was separated that oestradiol may also act directly in a receptor-dependent from unbound DNA in non-denaturing polyacrylamide gels and visualway to stimulate a tyrosine kinase/p21ras/MAP-kinase ized by autoradiography.
pathway in MCF-7 breast cancer cells (Migliaccio et al., Ligand-binding analysis of the wild-type and mutant receptors was 1996) indicates a convergence of multiple signalling performed as described previously (Fawell et al., 1990a) which promotes the interaction with co-activator proteins may, therefore, provide an alternative mechanism of GST pull-down assays The ligand-binding domains of wild-type and mutant ERs were expressed activating ER-mediated transcription.
as GST fusion proteins in Escherichia coli as has been described previously . For GST pull-down assays, bacterially expressed GST or GST fusion proteins were bound to glutathione-
Materials and methods
Sepharose 4B beads (Pharmacia Biotech). RIP-140 and SRC-1 cDNAs in pBluescript vectors were used to generate [ 35 S]methionine-(Amersham Plasmids International) labelled proteins using the TNT-coupled in vitro translation The following plasmids have been characterized previously: GAL4-AF2 system (Promega). The 35 S-labelled proteins were incubated with beads and GST-AF2 , pMT2 MOR (Lahooti et al., containing either GST or GST fusion proteins in the absence or presence 1995), pBluescript-RIP-140 and pEFBOS-RIP-140 (Cavaillès et al., of 10 -6 M oestradiol or 4-hydroxytamoxifen, in NETN buffer (0.5% 1995) , pERE TK-LUC and p(GAL) 5 CAT (Lillie NP-40, 20 mM Tris-HCl pH 8.0, 200 mM NaCl, 1 mM EDTA) and Green, 1989) . The SRC-1 cDNA was amplified from a human B containing protease inhibitors. After an overnight incubation, free proteins cell library using oligonucleotides based on the original sequence (Onate were washed away from the beads with NETN buffer. Bound proteins et al., 1995) , and cloned into pBluescript SKϩ (Stratagene) and the were extracted into loading buffer, separated by SDS-PAGE and visualeukaryotic expression vector pSG5 (Green et al., 1988) .
ized by fluorography. The amounts of bound [ 35 S]proteins were quantified Mutated receptors were constructed by the insertion of oligonucleousing a PhosphorImager (Molecular Dynamics). tide cassettes between unique KpnI and ClaI sites previously introduced at the positions of amino acids 538 and 552 into the mouse ER Protein-protein interaction assays in the presence of DNA cDNA sequence in pSP65MOR. To construct Y541-F, the oligoThe analysis of interactions between co-activators and receptors bound nucleotide GTACCCCTCTTTGACCTGCTCCTAGAGATGCTTGATGto DNA was carried out according to the method of Kurokawa et al. CCCAT together with the complementary strand were synthesized. Other (1995) with minor modifications. Approximately 50 μg of COS-1 cell mutations were made with the oligonucleotide GTACCCCTCGMKGextract transiently expressing the wild-type (MOR 1-599) and mutant ACCTGCTCCTAGAGATGCTTGATGCCCAT and the complementary forms of the receptor was incubated with 1 μg of double-stranded strand. All mutations were confirmed by DNA sequencing. The mutated biotinylated oligonucleotides containing the oestrogen response element. cDNA sequences were then transferred into the mammalian expression
The complexes were immobilized on streptavidin MagneSphere paravector pMT2 and verified for the mutation and orientation by sequence magnetic beads (Promega) and, after incubation with 17β-oestradiol or analysis and by restriction enzyme analysis respectively. no hormone, [ 35 S]methionine-labelled in vitro translated RIP-140 or SRC-1 was added. After washing, the radiolabelled proteins were eluted, Transient transfection experiments separated by SDS-polyacrylamide gels and detected by fluorography. HeLa cells routinely were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum (FBS, Gibco). For transient transfection assays, the cells were maintained in phenol red-Jones and Peter Parker, together with David Heery and members of the of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J., 11, 1025-1033. Molecular Endocrinology Laboratory, for discussions and comments on the manuscript. This work was supported by grants from The Netherlands Durand,B., Saunder,M., Gaudon,C., Roy,B., Losson,R. and Chambon,P.
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